Loading clinical trials...
Loading clinical trials...
Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis
Conditions
Interventions
Tocilizumab
Locations
31
United States
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas, United States
University of Chicago Hospital
Chicago, Illinois, United States
Hackensack University Medical Center; Pediatric Rheumatology
Hackensack, New Jersey, United States
Duke University
Durham, North Carolina, United States
Cincinnati Children'S Hospital Medical Center; Division of Rheumatology
Cincinnati, Ohio, United States
Cleveland Clinic Fndn
Cleveland, Ohio, United States
Start Date
July 16, 2014
Primary Completion Date
November 24, 2021
Completion Date
November 24, 2021
Last Updated
February 23, 2022
NCT06838143
NCT06870045
NCT05534347
NCT04902807
NCT04833465
NCT03245801
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions